In terms of tolerability, tirzepatide generally causes fewer gastrointestinal side effects, making it a better option for those sensitive to nausea, while Semaglutide GLP-1 may cause mild to moderate gastrointestinal issues like nausea and diarrhea, which usually subside over time
Neither compound, in any formulation, can be legally dispensed as a pharmacy medicine as of this writing
Garcia-Fernandez M, Sierra I, Puche JE, Guerra L, Castilla-Cortazar I
it's about safeguarding the molecular structure of a sophisticated research tool to ensure your results are valid and reproducible
Neuroimage 54 , 28082821
TK was supported by the Schizophrenia Research Institute utilizing infrastructure funding from NSW Ministry of Health and a career development award from the National Health and Medical Research Council